Our Solutions   by Brands   Livmate   Orib 30 Tablets

Orib 30 Tablets

Orib 30 Tablets

*To be consumed as directed by physician.

Therapies:

Supportive

Composition:

Sorafenib Tosylate 200 mg

About Orib 30 Tablets

Orib 200 mg Tablets contains Sorafenib 200 mg, a targeted anticancer medicine belonging to the multi-kinase inhibitor (tyrosine kinase inhibitor) class. It is prescribed for the treatment of liver cancer (hepatocellular carcinoma), advanced kidney cancer (renal cell carcinoma), and differentiated thyroid cancer that no longer responds to radioactive iodine therapy. Sorafenib works by blocking proteins involved in cancer cell growth and the formation of new blood vessels that supply tumors, thereby slowing the growth and spread of cancer. Orib 200 mg Tablets should be used only under the supervision of a qualified oncologist.

Orib 30 Tablets

*To be consumed as directed by physician.


Usage Instructions

  • Take Orib 200 mg Tablets exactly as prescribed by your doctor.
  • It should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal, or with a low-fat meal if advised by your doctor.
  • Take the tablets at the same time each day to maintain consistent drug levels.
  • Continue treatment for the duration recommended by your oncologist.
  • Do not skip doses, change the dose, or discontinue treatment without medical advice.
  • Regular monitoring of blood pressure, liver function, kidney function, and overall health may be required during therapy.

    • Benefits and Use

  • Orib 200 mg Tablets is indicated for the treatment of hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma (kidney cancer), and differentiated thyroid cancer.
  • Sorafenib works by blocking multiple kinases involved in tumour growth and blood vessel formation (angiogenesis), helping slow cancer progression and limit the spread of cancer cells.
  • As part of targeted cancer therapy, it helps improve disease control and treatment outcomes when used under specialist supervision.

    • Safety Information

  • Pregnancy:
  • Orib should not be used during pregnancy unless the potential benefit clearly outweighs the risk to the unborn baby. Effective contraception should be used by both men and women during treatment and for the period advised by your doctor after therapy.
  • Breastfeeding:
  • Breastfeeding is not recommended during treatment, as Sorafenib may pass into breast milk and harm the infant.
  • Alcohol:
  • Consult your doctor before consuming alcohol during treatment.
  • Kidney Disorders:
  • Use with caution in patients with severe kidney disease. Regular monitoring of kidney function may be required.
  • Liver Disorders:
  • Patients with severe liver disease require careful monitoring, and dose adjustments may be necessary.
  • Blood Pressure:
  • Sorafenib may increase blood pressure; regular blood pressure monitoring is recommended throughout treatment.
  • Skin Reactions:
  • Inform your doctor immediately if you develop severe skin rash, redness, pain, swelling, or blisters on the hands and feet (hand-foot skin reaction).
  • Driving:
  • If you experience dizziness, fatigue, or symptoms affecting concentration, avoid driving or operating machinery.
  • Inform your doctor about all medicines you are taking before starting treatment, as Sorafenib may interact with other medications.

    • Ingredients

    Sorafenib 200 mg

    How to Use

  • Swallow one Orib 200 mg Tablets whole with a full glass of water.
  • Do not crush, chew, or break the Tablets.
  • Take it on an empty stomach or with a low-fat meal, exactly as directed by your healthcare professional.
  • Maintain adequate hydration throughout treatment.

    • Storage Information

    Store below 30°C in a cool, dry place, protected from heat, moisture, and direct sunlight.